ADVANCED HR+/HER2- BREAST CANCER
Clinical trials for ADVANCED HR+/HER2- BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HR+/HER2- BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED HR+/HER2- BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control advanced breast cancer
Disease control Not yet recruitingThis study tests a new drug called ERW316, alone or with hormone therapy, in people with advanced HR+/HER2- breast cancer or other solid tumors that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug can help control the disease. A…
Matched conditions: ADVANCED HR+/HER2- BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New study aims to stop chemo side effect in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether giving atropine before chemotherapy can prevent severe diarrhea in people with advanced breast cancer. About 30 participants will receive atropine alongside the drug sacituzumab govitecan. The goal is to make treatment more tolerable by reducing a common …
Matched conditions: ADVANCED HR+/HER2- BREAST CANCER
Phase: PHASE2 • Sponsor: MedSIR • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC